What is Buspirone Used For?
Buspirone is FDA-approved for the management of generalized anxiety disorder (GAD) and for short-term relief of anxiety symptoms. 1
Primary Indication: Generalized Anxiety Disorder
Buspirone is specifically indicated for patients whose diagnosis corresponds to GAD, characterized by persistent anxiety lasting at least 1 month with symptoms including:
- Motor tension (shakiness, trembling, muscle aches, restlessness)
- Autonomic hyperactivity (sweating, pounding heart, dry mouth, dizziness)
- Apprehensive expectation (worry, fear, rumination)
- Vigilance and scanning (hyperattentiveness, difficulty concentrating, insomnia, irritability) 1
The drug has demonstrated efficacy in controlled clinical trials of outpatients with GAD, including those with coexisting mild depressive symptoms. 1
Secondary Clinical Uses
Augmentation in Major Depressive Disorder
Buspirone serves as an augmentation agent for antidepressant therapy in major depressive disorder. Evidence of moderate certainty shows that augmenting an antidepressant with buspirone achieves similar efficacy to switching antidepressants or augmenting with bupropion SR as a second-step treatment strategy. 2
Anxiety in Autism Spectrum Disorder
For anxiety in autistic patients, buspirone is recommended as a first-line pharmacological option, preferred over SSRIs due to better tolerability and effectiveness profiles specific to this population. 3
Mechanism and Pharmacology
Buspirone is an azapirone that acts as a partial agonist at serotonin 5-HT1A receptors and antagonist at dopamine D2 autoreceptors, with weak affinity for 5-HT2 receptors. 4 This differs fundamentally from benzodiazepines—buspirone lacks anticonvulsant and muscle-relaxant properties, causes minimal sedation, and has no potential for addiction or abuse. 5, 6
Important Clinical Considerations
Onset of Action
Patients must be counseled that buspirone has a gradual onset of action (typically 3-4 weeks) and does not provide immediate relief or euphoria like benzodiazepines. 5 This is critical for managing expectations and preventing premature discontinuation.
Dosing
- Standard dosing: 15-60 mg/day in divided doses
- Elderly patients require similar doses to younger adults (mean 18 mg/day) 7
- Pediatric use (ages 6-17) showed no significant benefit over placebo at studied doses 1
Contraindications and Cautions
- Avoid in severe hepatic or renal impairment due to increased plasma levels and prolonged half-life 1
- Safe in elderly patients receiving multiple concomitant medications for chronic conditions 7
- No psychomotor impairment or alcohol potentiation 5
- Can be used in nursing mothers only if clinically necessary, as excretion in breast milk occurs 1
Limited Evidence Areas
Buspirone's efficacy in panic disorder remains inconclusive and is not recommended for routine panic disorder treatment. 8 Long-term use beyond 3-4 weeks lacks controlled trial evidence, though one study showed safety for 1 year of continuous use. 1